Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24
Filtrar
2.
Zhonghua Er Ke Za Zhi ; 56(7): 511-517, 2018 Jul 02.
Artículo en Chino | MEDLINE | ID: mdl-29996184

RESUMEN

Objective: To evaluate the long-term efficacy and prognostic factors of childhood acute lymphoblastic leukemia (ALL) enrolled in Shanghai Children's Medical Center-Acute Lymphoblastic Leukemia-2005(SCMC-ALL-2005) multicenter study. Methods: Between May 2005 and December 2014, 1 497 newly diagnosed ALL patients were enrolled and treated in 5 hospitals of SCMC-ALL-2005 study group, using risk-stratified SCMC-ALL-2005 protocol. Risk group classification and treatment intensity were based on clinical features, genetic abnormalities, early response to treatment and levels of minimal residual disease (MRD). Kaplan-Meier method was used to generate overall survival (OS) and event-free survival(EFS) curves. Cox proportional hazards models were used for multivariate analyses. Results: The patients were followed up to December 31, 2016, the median follow-up time was 69 months (24-141 months). The 5-year and 10-year OS rates were (80.0±1.0)% and (76.0±2.0)%. The 5-year and 10-year EFS rates were (69.0±1.0)% and (66.0±2.0)%. The 5-year and 10-year relapse rates were (23.0±1.0)% and (25.0±2.0)%. The 5-year OS and EFS for low risk (LR), intermediate risk (IR) and high risk (HR) were (91.1±1.4)% and (83.3±1.8)%, (79.2±1.5)% and (68.9±1.7)%, (52.9±4.4)% and (30.0±3.8)%, respectively. MRD negative status (<0.01%) on day 55 was seen in 792 patients (82.8%) and positive MRD on day 55 was associated with poor prognosis (OR=1.9, 95%CI: 1.3-2.7, P=0.001). Twenty-four HR patients received allogeneic hematopoietic stem cell transplantation and 17(70.8%) of them were alive and in remission. A total of 164 severe adverse events occurred, 46 of them died, treatment-related mortality was 3.1%. Conclusions: In this large sample research, the overall outcome for multi-center SCMC-ALL-2005 study was favorable. This helps to promote the standardized treatment of childhood ALL to the whole country. MRD results on day 55 of induction therapy have important prognostic and therapeutic implications.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica , Trasplante de Células Madre Hematopoyéticas , Leucemia-Linfoma Linfoblástico de Células Precursoras , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Niño , China , Supervivencia sin Enfermedad , Humanos , Neoplasia Residual , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamiento farmacológico , Pronóstico , Inducción de Remisión , Resultado del Tratamiento
4.
Zhonghua Nei Ke Za Zhi ; 56(6): 409-413, 2017 Jun 01.
Artículo en Chino | MEDLINE | ID: mdl-28592039

RESUMEN

Objective: To investigate the prevalence of metabolic syndrome (MS) among adults in rural areas of Ningxia Hui autonomous region. Methods: A cross-sectional study was conducted in 10 639 adults enrolled with a multistage method from Jingyuan County. The MS was identified according to Chinese type 2 diabetes prevention guide (2013). Results: Among all the subjects, 17.4% of them met the MS definition with the standardized prevalence of 14.7% after adjustment of sex and age. The prevalence and standardized rate of MS in men were 19.9% and 17.3%, and in women were 15.3% and 13.5%.The prevalence of MS in men was higher than that in women(P<0.001) and increased with aging in both genders. The prevalence and standardized rate of abdominal obesity, hyperglycemia, hypertension, high triglycerides, and low HDL-C were 19.5% and 16.7%, 15.0% and 12.9%, 42.0% and 37.1%, 25.8% and 23.1%, 28.5% and 27.7%, respectively. The rate of abdominal obesity was higher in women than in men (20.5% vs 18.2%, P=0.004), whereas the rate of hypertension, high triglycerides, and low HDL-C were higher in men than in women (all P<0.01). The prevalence of having one parameter of the MS was 68.4%. Conclusion: The prevalence of MS is higher in rural areas of Ningxia Hui autonomous region, suggesting that a series of comprehensive prevention measures should be carried out to prevent and control the MS so as to improve the public health conditions in rural areas.


Asunto(s)
Pueblo Asiatico/estadística & datos numéricos , Síndrome Metabólico/epidemiología , Adulto , Pueblo Asiatico/etnología , China/epidemiología , Estudios Transversales , Diabetes Mellitus Tipo 2/epidemiología , Femenino , Humanos , Hipertensión/epidemiología , Hipertrigliceridemia , Masculino , Persona de Mediana Edad , Obesidad Abdominal/epidemiología , Prevalencia
5.
Zhonghua Gan Zang Bing Za Zhi ; 25(1): 65-68, 2017 Jan 20.
Artículo en Chino | MEDLINE | ID: mdl-28297787

RESUMEN

At present, the most effective therapeutic method for end-stage liver fibrosis is liver transplantation. However, the application of liver transplantation is limited by a shortage of liver donors, a high incidence rate of surgical complications, graft-versus-host disease, and high medical costs. Umbilical cord mesenchymal stem cell (UC-MSC) transplantation may become a promising method for the treatment of liver diseases. UC-MSCs are adult stem cells which exhibit multipotential differentiation and can differentiate into hepatic parenchymal cells. Due to their functions including immune regulation and secretion of trophic factors, UC-MSCs can inhibit immune response, promote hepatocyte regeneration, alleviate the progression of liver fibrosis, and improve liver function. In addition, compared with bone marrow mesenchymal stem cells, UC-MSCs have abundant sources, noninvasive collection, and high safety and thus they are attracting more and more attention. This article reviews the characteristics of UC-MSCs and their mechanism of action in the treatment of liver fibrosis, as well as risks of UC-MSCs therapy.


Asunto(s)
Cirrosis Hepática/terapia , Trasplante de Células Madre Mesenquimatosas , Células Madre Mesenquimatosas/citología , Cordón Umbilical/citología , Adulto , Diferenciación Celular , Enfermedad Injerto contra Huésped , Hepatocitos/citología , Humanos , Trasplante de Hígado
6.
Artículo en Chino | MEDLINE | ID: mdl-29771041

RESUMEN

Objective:The aim of this study is to retrospective analysis the clinic features of 118 cases of benign paroxysmal positional vertigo after trauma. Method:Analyzes clinic features of injury in 118 cases of benign paroxysmal positional vertigo after trauma, and classified and localized the craniocerebral trauma. The 118 cases were tested with different positioning tests in the sequence of Dix hallpike test and rolling test. Then, proper otolith manual reduction was given. Result:In 118 cases of BPPV after trauma including 35 cases of skull fracture, 6 cases of concussion, 17 cases of scalp hematoma, 28 cases of scalp laceration, 14 cases of mild brain contusion and 18 cases of head combined injury. The distributions of head injury were 57 at front temporal, 24 at top, 22 at occipital and 15 at maxillofacial region. The latency of BPPV after head injury varies from 1day to 1month. The incidence of 3-7 day after head injury was the highest, followed by 7-14 days, 0-3 days, and the lowest incidence rate of 14 day to 1 month. Canal type 118 BPPV patients after head injury accounting for up to 57.6% of the horizontal semicircular canal accounted for 33.1%, mixed 9.3%. Conclusion:The patients with front temporal trauma and skull fracture were prone to have BPPV. The peak incidence of BPPV was 3-14 days after head injury. The most common type of BPPV was PC BPPV, and the HC BPPV was the second type. A good curative effect can be manipulative reduction after trauma BPPV..


Asunto(s)
Vértigo Posicional Paroxístico Benigno/etiología , Heridas y Lesiones/complicaciones , Vértigo Posicional Paroxístico Benigno/fisiopatología , Humanos , Membrana Otolítica/lesiones , Estudios Retrospectivos , Cuero Cabelludo , Canales Semicirculares/lesiones
7.
Zhonghua Er Ke Za Zhi ; 54(6): 456-60, 2016 Jun 02.
Artículo en Chino | MEDLINE | ID: mdl-27256235

RESUMEN

OBJECTIVE: To explore the incidence, clinical characteristics and prognosis of childhood T-cell acute lymphoblastic leukemia (T-ALL) enrolled in protocol ALL-2005. METHOD: Retrospective reviews of patients diagnosed as having T-ALL were studied in the period between May 2005 and August 2013 in Shanghai Children's Medical Center. Predictive values of early treatment responses, including prednisone response, bone marrow morphology on day 35 during induction chemotherapy, and minimal residual disease (MRD) monitored by flow cytometry on day 35 and 55, were analyzed. The Kaplan-Meier method was used to assess the survival rates. RESULT: Ninety-nine evaluable patients aged 1-18 years with newly diagnosed T-ALL were enrolled in protocol ALL-2005. The median follow-up period for patients remaining alive in continuous remission was 60 months (24-109 months). The 5-year event free survival (EFS) and overall survival (OS) rates for these patients were 65% and 69%, respectively. Forty-three (43%) patients were older than 10 years at diagnosis. A total of 61 patients presented with initial white blood cell count (WBC)≥50×10(9)/L. Thirty-seven patients with mediastinal mass were found in this study. Seventy-one patients were defined as prednisone good responders (PGR) on day 8 of prednisone therapy. Ninty-four patients achieved complete remission (CR) on day 35 of induction therapy. MRD negative status (<0.01%) on day 35 were seen in 55% of the 42 assessed patients. MRD negative status on day 55 was seen in 78% of the 52 assessed patients. Patients with high MRD (>1%) on day 55 5-year EFS was 40% were associated with poor prognosis (P=0.03). Early T-cell precursor (ETP) subtype was not associated with treatment outcome in this study. Six patients abandoned therapy, 10 lost to follow-up, 22 had relapsed disease, 1 was diagnosed as having a second tumor and 20 patients died. CONCLUSION: Overall outcome for T-ALL on protocol ALL-2005 is favorable. MRD results on day 55 of induction therapy have important prognostic and therapeutic implications.


Asunto(s)
Leucemia-Linfoma Linfoblástico de Células T Precursoras/diagnóstico , Médula Ósea/patología , Niño , China , Supervivencia sin Enfermedad , Citometría de Flujo , Humanos , Recuento de Leucocitos , Perdida de Seguimiento , Neoplasia Residual/diagnóstico , Leucemia-Linfoma Linfoblástico de Células T Precursoras/terapia , Prednisona/uso terapéutico , Pronóstico , Inducción de Remisión , Estudios Retrospectivos , Tasa de Supervivencia , Resultado del Tratamiento
8.
Genet Mol Res ; 14(4): 13894-905, 2015 Oct 30.
Artículo en Inglés | MEDLINE | ID: mdl-26535705

RESUMEN

In order to investigate how photoperiod affects the expression of KiSS-1/G-protein-coupled receptor 54 (GPR54), the hypothalamus, the ovaries and testicles of the striped hamster were studied following photoperiod treatment and melatonin injection. We found that the melatonin concentration in the blood of the striped hamster was consistent with the treated photoperiods and that the photoperiod had significant effects on KiSS-1 expression, but the effect of photoperiod on GPR54 expression differed among tissues and sexes. The relative expression of KiSS-1 in the gonads of the male and female striped hamster was significantly higher than that in the hypothalamus, while the difference in GPR54 between the gonads and hypothalamus was inconsistent between the male and female striped hamster. In the striped hamster injected with melatonin, the expression level of KiSS-1 in the gonads and hypothalamus of the male and female striped hamster was significantly decreased; the expression level of GnRH in the gonads was also significantly decreased; the expression of GPR54 in the hypothalamus was increased. In the hypothalamus, a significant positive correlation existed between KiSS-1 and GnRH expression, while a negative correlation was observed between GPR54 and GnRH expression. These results suggest that the photoperiod-melatonin-KiSS-1-GnRH pathway plays an important role in the seasonal reproduction mechanism of the striped hamster. Additionally, photoperiod or melatonin may not be a direct regulatory factor of GPR54 expression.


Asunto(s)
Regulación de la Expresión Génica , Kisspeptinas/genética , Fotoperiodo , Receptores Acoplados a Proteínas G/genética , Animales , Cricetinae , Femenino , Hormona Liberadora de Gonadotropina/sangre , Hormona Liberadora de Gonadotropina/metabolismo , Masculino , Melatonina/sangre , Melatonina/metabolismo , Especificidad de Órganos/genética , Factores Sexuales
9.
Transplant Proc ; 47(2): 412-8, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25769583

RESUMEN

We aimed to evaluate clinical therapeutic effects of human umbilical cord-derived mesenchymal stem cell (UCMSC) transplantation in the treatment of end-stage liver diseases. The human UCMSCs were cultured and prepared, and then transplanted into the hepatic tissues of 50 patients with decompensated cirrhosis. The liver function, thrombin function, Model for End-Stage Liver Disease (MELD) score, and hemodynamic index value were detected during a 24-week follow-up period, with the addition of hepatoprotective, antiviral, and other conventional treatments. No complications or serious side effects were observed. In the first 2-3 weeks after surgery, symptoms including abdominal distension, oliguria, edema, and others decreased significantly, with increased appetite compared with before surgery. In the 24-week follow-up period, the levels of serum albumin and prealbumin increased significantly compared with the preoperative levels; the decrease of coagulation indicators was not significant. The MELD scores were also markedly increased. Alpha-fetoprotein levels increased without significance after treatment. There was no significant difference in the hemodynamic changes in the portal and splenic veins according to ultrasound. Moreover, no significant differences in the liver and thrombin functions between the hepatitis B virus group and the other-etiology group were observed.


Asunto(s)
Enfermedad Hepática en Estado Terminal/terapia , Trasplante de Células Madre Mesenquimatosas/métodos , Células Madre Mesenquimatosas/citología , Cordón Umbilical/citología , Adulto , Anciano , Células Cultivadas , Femenino , Humanos , Masculino , Persona de Mediana Edad
10.
Anim Reprod Sci ; 153: 44-9, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-25563157

RESUMEN

The study was conducted to investigate the serum hormone concentrations and follicular dynamics present after synchronous treatment (CIDR) in female Jilin sika deer (n = 15) of estrous cycles. Blood samples were collected to analyze the FSH, LH, estradiol and progesterone during the estrous cycles. Manual transrectal ultrasonography examination was conducted at least thrice weekly to monitor the follicular wave. Ultrasonography showed that follicle development occurred in waves, and most estrous cycles in Jilin sika deer consist of one, two, or three waves. The largest follicles of the interwaves of two- and three-wave cycles were different (P < 0.05). The mean interovulatory interval was 15.0 ± 4.6 d. There was a surge in circulating FSH in two- and three-wave cycles. The emergence of the largest follicle was related to the peak of serum concentration of estradiol. Serum progesterone concentrations were not different between one- and three-wave cycles (P < 0.05). We concluded that FSH and estradiol concentration may have an important role in controlling follicular development, that the estrous cycle in Jilin sika deer is characterized by one, two, or three waves of follicular development after synchronization.


Asunto(s)
Ciervos/fisiología , Estradiol/sangre , Sincronización del Estro , Hormona Folículo Estimulante/sangre , Hormona Luteinizante/sangre , Folículo Ovárico/fisiología , Progesterona/sangre , Animales , Ciclo Estral/sangre , Sincronización del Estro/métodos , Sincronización del Estro/fisiología , Femenino , Dispositivos Intrauterinos Medicados/veterinaria , Reproducción/fisiología , Estaciones del Año
11.
Acta Neurol Scand ; 121(4): 217-24, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19951274

RESUMEN

OBJECTIVES: The safety and efficacy of early acetylcholinesterase inhibitors therapy in patients with cognitive impairment no dementia (CIND) after a cerebrovascular accident have not been examined. In this study, we investigated the safety and efficacy of rivastigmine in cognition, particularly executive function in patients with CIND because of cerebrovascular disease. METHODS: This study was a 24-week, double-blind, randomized, placebo-controlled trial of ischemic stroke patients seen at a tertiary hospital who had cognitive impairment no dementia because of cerebrovascular disease. The intervention was either rivastigmine or placebo up to 9 mg/day. The primary outcome of interest was mean change from baseline in the Ten-Point Clock Drawing and Color Trails 1 and 2. RESULTS: Fifty patients were randomized into rivastigmine (n = 25) and placebo (n = 25) arms. Patients in the rivastigmine group showed statistically significant improvement (1.70 vs 0.13, P = 0.02) on the animal subtask of the verbal fluency measure compared with placebo. There was also a trend (non-significant) towards improvement in Color Trails II. CONCLUSIONS: In this pilot study, we demonstrated that rivastigmine was well tolerated in patients with CIND because of cerebrovascular disease and may potentially improve executive functioning.


Asunto(s)
Isquemia Encefálica/complicaciones , Inhibidores de la Colinesterasa/administración & dosificación , Trastornos del Conocimiento/tratamiento farmacológico , Trastornos del Conocimiento/etiología , Función Ejecutiva/efectos de los fármacos , Fenilcarbamatos/administración & dosificación , Accidente Cerebrovascular/complicaciones , Anciano , Anciano de 80 o más Años , Inhibidores de la Colinesterasa/efectos adversos , Demencia/tratamiento farmacológico , Demencia/etiología , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Fenilcarbamatos/efectos adversos , Proyectos Piloto , Rivastigmina , Resultado del Tratamiento
13.
Blood ; 86(10): 3848-60, 1995 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-7579353

RESUMEN

Apoptotic cell death induced by cross-linking Fas receptor (FasR/CD95) has been investigated in human acute myelogenous leukemia (AML) cells. FasR-mediated growth inhibition and DNA fragmentation could be induced in certain cases of AML. Interestingly, when DNA synthesis and G1 -> S transition in the cell cycle were enhanced by interleukin-3 or granulocyte-macrophage colony-stimulating factor, Fas-insensitive blast cells acquired cellular susceptibility toward FasR-mediated growth inhibition. To further evaluate an association between the Fas-R-mediated action and a specific phase of the cell cycle, a FasR+ leukemic cell line, MML-1, was established from a patient with AML. The morphologic feature of dying cells and DNA fragmentation indicated that FasR cross-linking induced apoptotic cell death in MML-1 cells. Cell cycle arrest in G1A phase with the treatment of phorbol 12-myristate 13-acetate or thymidine rendered MML-1 cells resistant to FasR-mediated apoptosis without downregulation of surface FasR expression. However, S-phase arrest with 5-fluorouracil could neither enhance nor inhibit FasR-mediated apoptosis. Simultaneous DNA/RNA quantification analysis revealed the selective loss of cells in G1B compartment, accompanied by the increase of apoptotic nuclei in sub-G1 fraction. These findings suggested that FasR-mediated apoptotic signals could be transduced into cells in G1B compartment and G1A -> G1B transition might augment the induction of FasR-mediated apoptosis.


Asunto(s)
Apoptosis/fisiología , Fase G1 , Leucemia Mieloide/patología , Células Madre Neoplásicas/citología , Transducción de Señal , Receptor fas/fisiología , Enfermedad Aguda , Anticuerpos Monoclonales/inmunología , Anticuerpos Monoclonales/farmacología , División Celular/efectos de los fármacos , Niño , Preescolar , Daño del ADN , ADN de Neoplasias/análisis , Fluorouracilo/farmacología , Fase G1/efectos de los fármacos , Humanos , Células Madre Neoplásicas/efectos de los fármacos , ARN Neoplásico/análisis , Acetato de Tetradecanoilforbol/farmacología , Timidina/farmacología , Células Tumorales Cultivadas , Receptor fas/inmunología
15.
Undersea Biomed Res ; 17(6): 535-41, 1990 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-2288044

RESUMEN

Comparisons between x-ray and B-mode ultrasonic examinations were carried out in 32 divers in both shoulders and both hips (128 comparisons in all). The x-rays showed dysbaric osteonecrosis (DON) in 46 sites; in 43 of these, the B-mode ultrasonogram result coincided with the x-ray finding. We suggest that B-mode ultrasonograms can depict the location, form, and size of the lesions. It is an easy, efficient, and noninvasive method of diagnosing DON, worthy of further investigation and application. Similar good agreement between x-rays and ultrasonograms was found with the now-obsolete A-mode technique.


Asunto(s)
Buceo , Necrosis de la Cabeza Femoral/diagnóstico por imagen , Húmero , Osteonecrosis/diagnóstico por imagen , Humanos , Radiografía , Ultrasonografía
16.
Undersea Biomed Res ; 17(4): 353-8, 1990 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2396333

RESUMEN

In a prospective investigation of 164 cases of dysbaric osteonecrosis out of a total of 1269 hyperbaric workers, we found that lesions are apt to occur more frequently in some sites of the head and neck of the femur and humerus than in others. Defining the susceptibility of sites with radiographs has improved our ability to make early diagnoses because we are able to estimate the likelihood of a definite lesion of osteonecrosis developing. We have found that when the trabeculae in a susceptible site appear disordered or have translucent areas, the site often develops into osteonecrosis in a few years.


Asunto(s)
Buceo/efectos adversos , Fémur/patología , Húmero/patología , Osteonecrosis/diagnóstico , Fenómenos Biomecánicos , Enfermedad de Descompresión/complicaciones , Fémur/irrigación sanguínea , Fémur/fisiopatología , Cabeza Femoral/irrigación sanguínea , Cabeza Femoral/patología , Cabeza Femoral/fisiopatología , Cuello Femoral/irrigación sanguínea , Cuello Femoral/patología , Cuello Femoral/fisiopatología , Humanos , Húmero/irrigación sanguínea , Húmero/fisiopatología , Osteonecrosis/etiología , Osteonecrosis/fisiopatología
17.
Undersea Biomed Res ; 16(4): 271-4, 1989 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-2773158

RESUMEN

Rabbits developed acute decompression sickness after staying at 6 ATA for 30 min followed by decompression to 1 ATA in 20 min or less. If the rabbits received an i.v. injection of 25% ethanol upon surfacing, all survived, whereas half the untreated control group died within 15-35 min after decompressing. In ethanol-treated animals, no bubbles were seen in blood vessels of visceral organs, muscles, and subcutaneous tissues at autopsy 60 min after treatment. Decompression reduced platelet counts markedly in all rabbits, but in the control group the count stayed low, whereas with ethanol treatment the counts had reached the precompression level after 1 h and 24 h.


Asunto(s)
Enfermedad de Descompresión/tratamiento farmacológico , Etanol/uso terapéutico , Animales , Femenino , Masculino , Recuento de Plaquetas/efectos de los fármacos , Conejos , Tensión Superficial
18.
Undersea Biomed Res ; 15(5): 389-95, 1988 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-3201635

RESUMEN

Dysbaric osteonecrosis was found in 259 cases among 2260 examined hyperbaric workers from several occupations. No positive cases were found in the divers in shipyards and diving experiments. Naval divers showed the lowest incidence (2.1%) and fishery divers the highest (19.8%). Distribution of long bone lesions was 46.0% in upper humerus, 37.7% in upper femur, 8.3% in lower femur, and 8.0% in upper tibia. We classify long bone lesions into three radiographic stages, the first two on the basis of size of the bone lesions as projected on the radiographs, and the third stage on the basis of extension of the lesion toward articular destruction. The three-stage classification system correlates with the clinical symptoms, and the working capacity of the individual patients tends to correlate with the severity of dysbaric osteonecrosis and can be understood by the general public.


Asunto(s)
Buceo/efectos adversos , Enfermedades Profesionales/etiología , Osteonecrosis/etiología , China , Enfermedad de Descompresión/complicaciones , Humanos , Masculino , Enfermedades Profesionales/clasificación , Enfermedades Profesionales/diagnóstico por imagen , Osteonecrosis/clasificación , Osteonecrosis/diagnóstico por imagen , Radiografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA